BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 21344979)

  • 1. Feasibility of intraventricular nicardipine prolonged release implants in patients following aneurysmal subarachnoid haemorrhage.
    Barth M; Pena P; Seiz M; Thomé C; Muench E; Weidauer S; Hattingen E; Kasuya H; Schmiedek P
    Br J Neurosurg; 2011 Dec; 25(6):677-83. PubMed ID: 21344979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of nicardipine prolonged release implants (NPRI) in microsurgical clipping after aneurysmal subarachnoid haemorrhage: comparison with endovascular treatment.
    Schneider UC; Dreher S; Hoffmann KT; Schmiedek P; Kasuya H; Vajkoczy P
    Acta Neurochir (Wien); 2011 Nov; 153(11):2119-25. PubMed ID: 21858650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicardipine Prolonged Release Implants for Prevention of Delayed Cerebral Ischemia after Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis.
    Akbik F; Waddel H; Jaja BNR; Macdonald RL; Moore R; Samuels OB; Sadan O
    J Stroke Cerebrovasc Dis; 2021 Oct; 30(10):106020. PubMed ID: 34365121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of nicardipine prolonged-release implants on cerebral vasospasm and clinical outcome after severe aneurysmal subarachnoid hemorrhage: a prospective, randomized, double-blind phase IIa study.
    Barth M; Capelle HH; Weidauer S; Weiss C; Münch E; Thomé C; Luecke T; Schmiedek P; Kasuya H; Vajkoczy P
    Stroke; 2007 Feb; 38(2):330-6. PubMed ID: 17185636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicardipine pellets for the prevention of cerebral vasospasm.
    Thomé C; Seiz M; Schubert GA; Barth M; Vajkoczy P; Kasuya H; Schmiedek P
    Acta Neurochir Suppl; 2011; 110(Pt 2):209-11. PubMed ID: 21125473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of nicardipine prolonged-release implants for preventing vasospasm in humans.
    Kasuya H; Onda H; Takeshita M; Okada Y; Hori T
    Stroke; 2002 Apr; 33(4):1011-5. PubMed ID: 11935053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicardipine prolonged-release implants for preventing cerebral vasospasm after subarachnoid hemorrhage: effect and outcome in the first 100 patients.
    Krischek B; Kasuya H; Onda H; Hori T
    Neurol Med Chir (Tokyo); 2007 Sep; 47(9):389-94; discussion 394-6. PubMed ID: 17895611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Super-selective intra-arterial magnesium sulfate in combination with nicardipine for the treatment of cerebral vasospasm in patients with subarachnoid hemorrhage.
    Shah QA; Memon MZ; Suri MF; Rodriguez GJ; Kozak OS; Taylor RA; Tummala RP; Vazquez G; Georgiadis AL; Qureshi AI
    Neurocrit Care; 2009; 11(2):190-8. PubMed ID: 19370322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twelve-year single critical care center experience of nicardipine prolonged-release implants in patients with subarachnoid hemorrhage: a propensity score matching analysis.
    Kuroi Y; Ohbuchi H; Arai N; Takahashi Y; Hagiwara S; Sasahara A; Funaki A; Itoh T; Sato Y; Kasuya H
    J Neurointerv Surg; 2020 Aug; 12(8):774-776. PubMed ID: 32034105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of intrathecal nicardipine on cerebral vasospasm in non-traumatic subarachnoid hemorrhage: a systematic review.
    Stuart D; Christian R; Uschmann H; Palokas M
    JBI Database System Rev Implement Rep; 2018 Oct; 16(10):2013-2026. PubMed ID: 30335041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The efficacy and safety of the nicardipine prolonged-release implant in a canine double hemorrhage model].
    Sasahara A; Kasuya H; Kawashima A; Aihara Y; Izawa M; Hori T
    No Shinkei Geka; 2000 Dec; 28(12):1071-5. PubMed ID: 11193527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventive Effect of Clazosentan against Cerebral Vasospasm after Clipping Surgery for Aneurysmal Subarachnoid Hemorrhage in Japanese and Korean Patients.
    Fujimura M; Joo JY; Kim JS; Hatta M; Yokoyama Y; Tominaga T
    Cerebrovasc Dis; 2017; 44(1-2):59-67. PubMed ID: 28463833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of functional outcome and quality of life following subarachnoid hemorrhage in patients treated with and without nicardipine prolonged-release implants.
    Barth M; Thomé C; Schmiedek P; Weiss C; Kasuya H; Vajkoczy P
    J Neurosurg; 2009 May; 110(5):955-60. PubMed ID: 19216650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Clot Removal by Meticulous Irrigation and Continuous Low-Dose Intravenous Nicardipine on Symptomatic Cerebral Vasospasm in Patients with Aneurysmal Subarachnoid Hemorrhage Treated by Clipping.
    Matsukawa H; Tanikawa R; Kamiyama H; Tsuboi T; Noda K; Ota N; Miyata S; Suzuki G; Takeda R; Tokuda S
    World Neurosurg; 2015 Dec; 84(6):1798-803. PubMed ID: 26278868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraventricular nicardipine for refractory cerebral vasospasm after subarachnoid hemorrhage.
    Goodson K; Lapointe M; Monroe T; Chalela JA
    Neurocrit Care; 2008; 8(2):247-52. PubMed ID: 17968520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and feasibility of intra-arterial nicardipine for the treatment of subarachnoid hemorrhage-associated vasospasm: initial clinical experience with high-dose infusions.
    Tejada JG; Taylor RA; Ugurel MS; Hayakawa M; Lee SK; Chaloupka JC
    AJNR Am J Neuroradiol; 2007 May; 28(5):844-8. PubMed ID: 17494654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
    Ehlert A; Schmidt C; Wölfer J; Manthei G; Jacobs AH; Brüning R; Heindel W; Ringelstein EB; Stummer W; Pluta RM; Hesselmann V
    J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of nicardipine prolonged-release implants after clipping for preventing cerebral vasospasm: from laboratory to clinical trial.
    Kasuya H
    Acta Neurochir Suppl; 2013; 115():41-4. PubMed ID: 22890641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Cilostazol on Cerebral Vasospasm and Outcome in Patients with Aneurysmal Subarachnoid Hemorrhage: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Matsuda N; Naraoka M; Ohkuma H; Shimamura N; Ito K; Asano K; Hasegawa S; Takemura A
    Cerebrovasc Dis; 2016; 42(1-2):97-105. PubMed ID: 27070952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracranial Administration of Nicardipine After Aneurysmal Subarachnoid Hemorrhage: A Review of the Literature.
    Dodson V; Majmundar N; El-Ghanem M; Amuluru K; Gupta G; Nuoman R; Wainwright J; Kaur G; Cole C; Santarelli J; Chandy D; Bowers C; Gandhi C; Al-Mufti F
    World Neurosurg; 2019 May; 125():511-518.e1. PubMed ID: 30708083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.